Purpose To evaluate the relationship between coronary artery calcium (CAC) and coronary vasodilator function. Methods We evaluated 136 patients without known coronary artery disease (CAD) undergoing vasodilator stress 82 Rb PET/CT and CAC scoring who showed normal myocardial perfusion. The CAC score, resting and hyperemic myocardial blood flow (MBF), coronary flow reserve (CFR) and coronary vascular resistance were analyzed. Results Global and regional CAC scores showed significant but weak inverse correlations with hyperemic MBF (r=−0.31 and r=−0.26, p≤0.0002 respectively) and CFR (r=−0.28 and r=−0.2, p≤0.001 respectively). With increasing CAC score, there was a modest stepwise decline in CFR on a per-patient basis (1.8±0.5 vs 1.7±0.5 vs 1.5±0.4, p=0.048, with total CAC=0, 1-400 and >400, respectively) and on a per-vessel basis. In multivariable modeling only body mass index and CAC score were predictive of CFR. Conclusion In patients with an intermediate likelihood of, but without overt, CAD, there is a statistically significant but weak inverse correlation between CAC content and coronary vasodilator function. The strength of this association weakens after adjusting CAC scores for age, gender and coronary risk factors. This suggests that CAC and coronary vasodilator function provide biologically different information regarding atherosclerosis.
coronary artery disease (CAD) has been interpreted as a sign of clinical stability and that calcification likely represents a healing response [3, 4] . However, data from several large prospective studies demonstrating a stepwise increase in coronary risk with increasing calcium scores challenge the notion that calcified CAD represents a scenario of clinical stability [3] [4] [5] [6] [7] [8] [9] . Indeed, conventional risk factors do not fully account for the excess coronary risk observed with increasing calcium scores. This suggests that other mechanisms may contribute to the association between coronary calcification and the increased risk of CAD. Since CAC is likely to reflect more widespread atherosclerosis, we reasoned that one such mechanism might involve the potential adverse effect of widespread atherosclerosis on vascular function, which would increase the potential for coronary vasoconstriction and thrombosis [10] .
Our objective was to determine the relationship between the magnitude of coronary calcification assessed by CT and coronary vasodilator function as assessed by quantitative PET imaging.
Material and methods

Patient population
We reviewed 200 consecutive patients who had completed combined rest-stress 82 Rb PET perfusion imaging and CAC scoring on a hybrid PET/CT scanner from November 2005 to August 2007. Because clinical PET data are collected in list mode, it is possible to reconstruct multiframe image datasets for myocardial blood flow (MBF) quantification. Patients were referred for cardiac PET/CT imaging for investigation of chest pain or nonclassic symptoms with multiple CAD risk factors, and CAC scoring was performed as a routine component of each study. Patients with known CAD (defined as a history of prior myocardial infarction and/or evidence of pathologic Q waves on resting electrocardiogram or prior revascularization) were excluded, as were those with cardiomyopathy (defined as left ventricular ejection fraction <40%), and/or conditions that would preclude reliable gated CT imaging for CAC assessment (arrhythmia, patient motion, presence of cardiac pacemaker or defibrillator leads).
In order to exclude the potential effect of epicardial obstruction on the relationship between CAC and flow, we excluded 64 patients with regional perfusion defects on stress PET imaging. Thus only 136 patients with normal regional perfusion on semiquantitative analysis were included in this analysis. The study was approved by the Partners Human Research Committee.
Clinical and historical data
Clinical histories elicited at the time of examination ascertained the presence or absence of various cardiac symptoms and risk factors, including chest pain, dyspnea, medications, family history of premature CAD, diabetes mellitus, hypertension, hyperlipidemia, and current or past cigarette smoking. Height and weight were recorded, and body mass index (BMI) was calculated. Pretest likelihood of CAD was assigned according to age, sex, symptoms and other risk factors, as described by Pryor et al. [11] .
Hybrid PET/CT imaging Patients were studied using a whole body PET/CT scanner (Discovery STE LightSpeed 64; GE Healthcare, Milwaukee, WI) following an overnight fast and 24-h cessation of all caffeine or methylxanthine-containing substances.
Assessment of myocardial blood flow MBF was measured at rest and during peak hyperemia using 82 Rb as a flow tracer. Following a scout CT scan (120 kVp, 10 mA) used for proper patient positioning, a CT transmission scan was acquired (140 kVp, 10 mA) for subsequent correction of photon attenuation. Beginning with the intravenous bolus administration of 82 Rb (1,480-2,220 MBq), serial images were acquired for 7 min as previously described [12] . Then, intravenous dipyridamole (0.142 mg/kg per minute for 4 min, n=129 patients) or adenosine (0.14 mg/kg per minute for 6 min, n=7 patients) was infused. At peak hyperemia, a second dose of 82 Rb (1,480-2,220 MBq) was injected and images were recorded using the same acquisition sequence. A second CT transmission scan was acquired (140 kVp, 10 mA) after vasodilator stress for attenuation correction of the stress emission data. The heart rate, systemic blood pressure, and 12-lead electrocardiogram were recorded at baseline and every minute during and after infusion of the vasodilator. The rate-pressure product was calculated by multiplying heart rate and systolic blood pressure measured at rest and during peak hyperemia, respectively.
Assessment of coronary artery calcification After myocardial perfusion imaging, the patients underwent a CT scan for CAC scoring on an integrated 64-slice multidetector CT scanner (collimation 64×0.625 mm, pitch 0.625:1, gantry rotation time 350 ms) using prospective gating at 80% of R-R interval. Breath-holding instructions were given to minimize misregistration. This gated CT scan (120 kV, 400 mA) was acquired and reconstructed using filtered back projection and a standard convolution kernel to 2.5-mm thick slices with a 512×512 matrix and a fixed 25-cm field of view.
Data analysis
Semiquantitative assessment of myocardial perfusion Attenuation-corrected perfusion images were processed for viewing in the standard cardiac axis projections. Semiquantitative visual interpretation of the rest and stress perfusion images was performed using a 17-segment heart model [13] . Segments were scored using the standard 5-point score (0 normal, 1 equivocal, 2 moderate and 3 severe reduction of radioisotope uptake, and 4 absence of detectable tracer uptake). Individual segmental scores were added together to obtain the summed stress score and summed rest score. The difference between the scores was defined as the summed difference score. An absolute summed stress score >1 was considered abnormal. Only patients with normal perfusion on semiquantitative PET interpretation were included in this analysis.
The semiquantitative assessment of myocardial perfusion was interpreted by two different readers (M.D.C. and S.D.). Interobserver variability for our laboratory was determined in a separate subgroup of 20 patients. Both readers concordantly grouped 19 of 20 scans as normal or abnormal. Interobserver agreement for scan interpretation was found to be excellent (kappa 0.95) with regard to the overall diagnosis of CAD.
Quantitative assessment of myocardial blood flow From the transaxial, attenuation-corrected perfusion images the right and left ventricular input functions were determined using Generalized Factor Analysis of the Dynamic Sequences software developed and validated at our institution [12] . The images were then reoriented into standard oblique planes (short axis, vertical and horizontal long axis of the heart) and myocardial time-activity curves for each cardiac segment were determined using regions of interest measurements. Parametric polar maps were constructed based on the standard 17-segment heart model [13] . Regional MBF in each of the three major coronary artery territories, i.e. left anterior descending (LAD) artery, left circumflex (LCX) artery, and right coronary artery (RCA) territories and global whole heart MBF were calculated by fitting the 82 Rb time-activity curves with a two-compartment tracer kinetic model and modeled extraction fraction [12, 14, 15] . The coronary flow reserve (CFR) was defined as the ratio between hyperemic and resting MBF. Coronary vascular resistance was calculated by dividing the mean arterial pressure by MBF.
Coronary artery calcium scoring CAC content was quantified using the method described by Agatston et al. [16] and semiautomated commercially available software (SmartScore, GE Healthcare). Coronary artery specific scores were calculated in the LAD artery (including calcium present in the left main coronary artery), LCX artery, and RCA and then summed to provide a total CAC score for each patient. The CAC score percentile ranks were determined for each individual patient based on gender and age-specific CAC distributions as previously published in a large database of patients [17] .
Statistical analysis
Continuous variables are presented as means±SD and ordinal variables are summarized by count and percentages. Differences in hemodynamic characteristics, MBF, CFR and coronary vascular resistance from rest to stress were assessed using a paired t-test. Spearman correlation coefficients were used to describe the relationship between CAC score and corresponding MBF, CFR or coronary vascular resistance on a per-patient and a per-vessel basis, respectively. Differences in MBF, CFR and coronary vascular resistance between groups stratified by CAC score were investigated using one-way ANOVA with Bonferroni correction for multiple pair-wise comparisons. The determinants of CFR were assessed by univariable and multivariable regression analysis. A p value less than 0.05 was used to define statistical significance. We used SAS statistical software for all analyses (version 9.1.3, SAS Institute, Cary, NC).
Results
Study patients
The baseline characteristics of the study patients are shown in Table 1 . In general, coronary risk factors were prevalent and the mean likelihood of CAD was intermediate. The CAC score ranged from 0 to 6,316 (mean 249±528). There were 44 patients (32%) with a CAC score of 0, 66 patients (49%) with a CAC score of 1-400, and 26 patients (19%) with a CAC score >400.
Systemic hemodynamics
With the infusion of dipyridamole, the heart rate and ratepressure product increased, whereas the systolic, diastolic and mean arterial blood pressure decreased significantly (Table 2) .
Per-patient analysis
Myocardial blood flow and coronary vascular resistance Baseline and peak MBF was regionally homogeneous and similar between the three coronary territories. During hyperemia, MBF increased and coronary vascular resistance decreased significantly compared to baseline (Table 3) .
Relationship between coronary artery calcium and vasodilator function
In the 136 patients, there was a statistically significant albeit weak inverse correlation between total CAC score and peak MBF (r=−0.31, p=0.0002) and estimates of CFR (r=−0.28, p=0.001), and a significant but weak direct correlation between CAC score and peak coronary vascular resistance (r=0.32, p=0.0002). There was no correlation between CAC score and baseline MBF (r=−0.14, p=0.1).
Stratification of patients into three groups based on their CAC scores (0, 1-400, >400) resulted in a modest stepwise reduction in mean peak MBF (1.9±0.6 vs 1.7±0.6 vs 1.4±0.5 ml/min/g, respectively, p=0.009), mean CFR (1.8±0.5 vs 1.7±0.5 vs 1.5±0.4, respectively, p=0.048), and a stepwise increase in mean peak coronary vascular resistance (53±20 vs 60±22 vs 72±21 mmHg/ml/min/g, respectively, p=0.003) with increasing levels of CAC content (Fig. 1) . No significant difference in mean baseline MBF was observed between the three CAC groups (p=0.1).
However, stratification of patients based on genderand age-specific percentiles of CAC (<25th, 25-75th, >75th percentile groups) [17] resulted in weaker and nonsignificant correlations between CAC content and measures of coronary vascular function. There was a nonsignificant stepwise decline in peak MBF (1.8±0.7 vs 1.7± 0.6 vs 1.5±0.6 ml/min/g, respectively, p=0.08) and CFR (1.8± 0.6 vs 1.7±0.5 vs 1.5±0.4, respectively, p=0.05), and a stepwise increase in mean peak coronary vascular resistance (56±21 vs 58±21 vs 67±23 mmHg/ml/min/g, respectively, p=0.06). No significant difference in resting MBF was observed between the CAC percentile groups.
Predictors of coronary flow reserve
In univariable analysis, predictors of CFR included hypertension (p=0.01), CAC score (p=0.01), BMI (p=0.01) and diabetes (p=0.02). In addition we used multivariable modeling that included factors known to be associated with impaired CFR (model 1: age, gender, history of hypertension, diabetes, dyslipidemia, smoking, and obesity represented by BMI) [18] . When all these factors were forced into the model only BMI (p=0.008) and history of hypertension (p=0.02) were independent predictors of CFR (model R 2 =0.15). When CAC score was added into this model (model 1 + CAC), only the BMI (p=0.005), and a Quantified using the method described by Agatston et al. [16] .
CAC score (p=0.04) remained predictive of CFR with improvement of the overall model (model R 2 =0.18; Table 4 ). However, variation in variables included in this final model (model 1 + CAC) explained only 18% of the variation in CFR.
We also performed multiple regression analysis including the same risk factors known to influence CFR using a stepwise selection process (model 2: age, gender, history of hypertension, diabetes, dyslipidemia, smoking, obesity represented by BMI, and CAC). In this analysis, the BMI (p=0.008), CAC (p=0.01), and history of hypertension (p=0.01) remained independently predictive of CFR (model 2 R 2 =0.14).
Per vessel analysis
Relationship between coronary artery calcium and vasodilator function
In the 136 patients, a total of 408 vascular territories were analyzed. Per-vessel CAC scores were correlated only marginally with peak MBF (r=−0.26, p<0.0001), CFR (r= −0.2, p<0.0001), and peak coronary vascular resistance (r=0.26, p<0.0001).
Stratification into groups of per-vessel CAC scores (0, 1-100, 101-400 and >400) resulted in modest stepwise reductions in mean peak MBF (1.8±0.7 vs 1.6±0.6 vs 1.5±0.5 vs 1.4±0.5 ml/min/g, respectively, p<0.0001) and mean CFR (1.8±0.6 vs 1.6±0.4 vs 1.5±0.5 vs 1.5±0.5, respectively, p=0.004), and a stepwise increase in mean peak coronary vascular resistance (55±21 vs 64±24 vs 65±21 vs 75±24 mmHg/ml/min/g, respectively, p<0.0001) with increasing levels of CAC (Fig. 2) .
Discussion
Coronary artery calcification seen on CT scanning has been assumed to be associated with clinical stability and to represent a healing response to atherosclerotic vascular complications [3, 4, 19] . However, the observation of excess cardiovascular risk beyond that accounted for by traditional risk factors in the setting of increased coronary calcification has challenged these assumptions [4] [5] [6] [7] [8] [9] . Since CAC is likely to reflect more widespread atherosclerosis, we hypothesized that one potential mechanistic link between CAC content and increased cardiovascular risk may involve the possible adverse effect of widespread atherosclerosis on vascular function. However, our findings demonstrate a rather weak inverse relationship between increasing levels of CAC content and measures of coronary vasodilator function, on both a per-patient basis and a pervessel basis. In multivariable modeling, including age, BMI and CAD risk factors, the CAC score remained a modest although statistically significant predictor of the CFR. In fact, the addition of CAC to the final model explained only an additional 3% of the variance in the relationship between factors known to influence vasodilator function and CFR. Biologically, these data seem to suggest that CAC content reflects primarily an anatomic measure of atherosclerotic burden.
The correlation between CAC content and coronary vascular dysfunction likely reflects the effects of coexisting coronary risk factors on endothelial and microvascular function [20] . Our results agree and extend the findings reported by Wang et al. [21] by demonstrating the interrelationship between coronary calcification and vasodilator function in a symptomatic population with higher clinical risk. These investigators reported the association of CAC and myocardial perfusion as assessed by magnetic resonance imaging during stress-and adenosine-induced hyperemia in 222 asymptomatic men and women enrolled in the Multi-Ethnic Study of Atherosclerosis. They also reported a modest but significant inverse correlation between CAC score and hyperemic MBF (r=−0.38, p<0.0001) and perfusion reserve (r=−0.35, p<0.0001). The mean hyperemic MBF and mean perfusion reserve were progressively lower with increasing CAC categories.
However, our findings differ from those reported by Pirich et al. [22] demonstrating no significant relationship between coronary calcification and vasoreactivity in a small group of 21 asymptomatic subjects with a family history of premature CAD. These investigators reported that CFR, as measured by 13 N-ammonia PET, was significantly related to age (r=0.4, p<0.05) but not to CAC score (r=0.18, p=NS). There was a significantly higher MBF during stress in subjects with a CAC score <100 compared to subjects with a CAC score >100 (2.55±5.3 vs 1.96±5.2 ml/min/g, p=0.03); however, no significant difference in CFR was observed between the two groups (3.48±0.55 vs 3.03 0±.84, p=NS). The apparent discrepancies with the results of our study may be related to differences in sample size and clinical risk.
Exactly how coronary calcification may affect vasodilator function in humans cannot be determined from this study. However, several potential mechanisms could explain the modest correlation between CAC and microvascular function. First, our results suggest that the inverse correlation between CAC and vasodilator function is explained in part by the coexistence of risk factors that are known to affect endothelial and microvascular function. Indeed, the strength of the association was weakened after adjusting the CAC scores by age and gender and for baseline risk factors in the multivariable analysis. Second, it is also possible that coronary calcification reflects more widespread atherosclerosis affecting both epicardial and resistance coronary arteries. It is estimated that for every calcified lesion there are many more noncalcified plaques that may more closely relate to diffuse inflammation of the coronary vasculature affecting vascular endothelial and smooth muscle cell function and hence, coronary vasoreactivity [10] . Finally, it is also possible that the observed inverse relationship between calcification and CFR may have been affected by the presence of occult CAD. However, because PET imaging is a sensitive approach for detection of CAD [23] [24] [25] and since we excluded patients with known CAD or overt stress perfusion defects, this is less likely.
Limitations
Our study consisted of an entirely physician referral-based diagnostic population with an intermediate likelihood of CAD. As such, this study design and the nature of patients referred to stress imaging limit the generalizability of our results to screening low-risk populations. Larger prospective studies investigating the relationship between myocardial perfusion reserve and coronary calcification could help confirm or extend our findings. Coronary angiography was not routinely performed as it was clinically unjustified in our patients with normal PET scans, and thus we cannot ascertain the potential effect of epicardial stenoses on the relationship between CAC and CFR. However, we excluded patients with known CAD and those with overt stress defects on PET imaging. Further, the available evidence [26] , including recent data from our laboratory [25] , indicate that PET has a sensitivity of >90% for detection of obstructive CAD. Furthermore, the fact that patients with normal perfusion PET scans have a very low frequency of adverse cardiac events (death and/or myocardial infarction) further supports the notion that the likelihood of high risk CAD in these patients was exceedingly low [27] [28] [29] [30] . While these considerations do not completely exclude the possibility of balanced ischemia in some of our patients, they makes it very unlikely that the weak correlation between CFR and CAC was actually due to inclusion of patients with multivessel CAD.
Conclusion
In patients with an intermediate likelihood of, but without overt, CAD, there was a statistically significant but weak inverse correlation between CAC content and coronary vasodilator function. The strength of this association weakened further after adjusting CAC scores for age, gender and for coronary risk factors. This suggests that CAC and coronary vasodilator function provide biologically different information regarding atherosclerosis. Future research should explore whether these measures of atherosclerotic disease burden and activity can be combined to improve noninvasive phenotypic characterization of a patient's clinical risk.
